Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Citi
McKinsey
Daiichi Sankyo
Cipla
Cerilliant
Fuji
Baxter
Queensland Health

Generated: November 19, 2018

DrugPatentWatch Database Preview

Silvergate Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SILVERGATE PHARMS, and what generic alternatives to SILVERGATE PHARMS drugs are available?

SILVERGATE PHARMS has four approved drugs.

There are thirteen US patents protecting SILVERGATE PHARMS drugs.

Summary for Silvergate Pharms
US Patents:13
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Silvergate Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 RX Yes Yes 9,855,214 ➤ Try a Free Trial Y ➤ Try a Free Trial
Silvergate Pharms EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 RX Yes Yes 9,669,008 ➤ Try a Free Trial Y ➤ Try a Free Trial
Silvergate Pharms EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 RX Yes Yes 10,039,745 ➤ Try a Free Trial Y ➤ Try a Free Trial
Silvergate Pharms QBRELIS lisinopril SOLUTION;ORAL 208401-001 Jul 29, 2016 RX Yes Yes 10,039,800 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for SILVERGATE PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Powder for Oral Solution 1 mg/mL ➤ Subscribe 2016-06-21
➤ Subscribe Oral Solution 1 mg/mL ➤ Subscribe 2018-08-31
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Medtronic
US Department of Justice
Teva
Fish and Richardson
Cerilliant
Federal Trade Commission
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.